Generalized Pustular Psoriasis (GPP) drugs in development, 2024

GlobalData tracks 6 drugs in development for Generalized Pustular Psoriasis (GPP) by five companies/universities/institutes. The top development phase for Generalized Pustular Psoriasis (GPP) is preclinical, with two drugs in that stage.